96 min listen
96| Polypharmacy in Older Adults – A Conversation With Dr. Mike Steinman and Dr. Matthew Growdon
96| Polypharmacy in Older Adults – A Conversation With Dr. Mike Steinman and Dr. Matthew Growdon
ratings:
Length:
96 minutes
Released:
Jun 1, 2022
Format:
Podcast episode
Description
Today we discuss polypharmacy and deprescribing with two geriatricians. We cover definitions of polypharmacy, inappropriate polypharmacy, deprescribing as an intervention, specific drug classes with potential for cognitive side effects in older adults, and a neuropsychologist’s role in clinical care related to polypharmacy. Show notes are available at www.NavNeuro.com/96 _________________ If you’d like to support the show, here are a few easy ways: 1) Get APA-approved CE credit for listening to select episodes: www.NavNeuro.com/INS 2) Tell your friends and colleagues about it 3) Subscribe (free) and leave an Apple Podcasts rating/review: www.NavNeuro.com/itunes 4) Contribute to the discussion in the comments section of the website (click the episode link listed above) or on Twitter (@NavNeuro) Thanks for listening, and join us next time as we continue to navigate the brain and behavior! [Note: This podcast and all linked content is intended for general educational purposes only and does not constitute the practice of psychology or any other professional healthcare advice and services. No professional relationship is formed between hosts and listeners. All content is to be used at listeners’ own risk. Users should always seek appropriate medical and psychological care from their licensed healthcare provider.]
Released:
Jun 1, 2022
Format:
Podcast episode
Titles in the series (100)
13| Disclosing Alzheimer’s Disease Genetic Risk – With Dr. Meghan Collier: Clinical trials in Alzheimer’s disease frequently include the measurement of risk genes (i.e., the APOE e4 allele), and advancements in direct-to-consumer genetic testing (e.g., 23andMe) have made these biological data widely available to the... by Navigating Neuropsychology